Naturex: Finasucre Group Acquires Dikansky Family's Holdings in SGD
Naturex, the global leader in speciality plant-based natural ingredients, informs its shareholders of the new ownership structure of the share capital of SGD, the company's lead shareholder.
26 Feb 2013 --- In July 2011, the Finasucre Group became a shareholder of SGD to strengthen the structure of this family holding company and provide it with resources to support Naturex in pursuing external growth opportunities.
Following Jacques Dikansky's passing and, in keeping with the spirit of the agreement concluded when Finasucre Group first became a SGD shareholder, Jacques Dikansky's children sold their entire stake in SGD.
Pursuant to the completion of this transaction on 22 February 2013, the Finasucre Group now holds 98.79% of SGD's share capital (21.0% of the company) with the balance held by selected members of Naturex's Executive Committee.
Finasucre Group's acquisition of these holdings is consistent with its initial investment in SGD and confirms its willingness to continue its long-term commitment in supporting Naturex in the implementation of its development strategy.
This transaction results in changes in the composition of Naturex's Board of Directors, pursuant to the resignation of Olivier Dikansky from his position as director, and the appointment of Charles Feys, Secretary General of Finasucre Group, as permanent representative of SGD, in replacement of Isabelle Dikansky.
The Board of Directors, in today's meeting, has also co-opted as a director, Hélène MARTEL-MASSIGNAC, Chief Executive Officer of CARAVELLE.
Pursuant to these changes, the composition of Naturex's Board of Directors is as follows:
• Thierry Lambert
Chairman and Chief Executive Officer of Naturex
• Stéphane Ducroux
Chief Operating Officer for the America/Asia-Pacific Regions
and Vice Chairman of Naturex Inc.
• Olivier Lippens
Executive Officer of Finasucre
• Paul Lippens
Executive Officer of Finasucre
• Hélène Martel-Massignac
Chief Executive Officer of Caravelle
• SGD
Represented by Charles Feys, Secretary General of Finasucre
It is furthermore reminded that the appointment of the FSI to Naturex's Board will be submitted to the next General Meeting.
